CFTC Chair Defends Landmark Approval of Perpetual Futures in the US Amid Industry Pushback
, ,

CFTC Chair Defends Landmark Approval of Perpetual Futures in the US Amid Industry Pushback

The Commodity Futures Trading Commission (CFTC) is standing firm on its decision to permit perpetual futures contracts within the United States. CFTC Chair Michael Selig recently addressed critics of the move, arguing that bringing these highly sought-after financial instruments onshore under a robust regulatory framework is essential for keeping pace with global financial innovation. Perpetual […]

China’s Economic Strain Deepens as Retail Sales Suffer First Contraction in Over Three Years
, , ,

China’s Economic Strain Deepens as Retail Sales Suffer First Contraction in Over Three Years

China’s economic recovery faces mounting hurdles as consumer spending and domestic investment faltered in May. Retail sales, a critical indicator of consumer demand, fell by 0.6% year-on-year, marking the first contraction since December 2022. Despite the early May Labor Day holiday, which typically boosts commercial activity, scaled-back government trade-in subsidies and heightened consumer price-consciousness left […]

Qualcomm CEO Predicts AI Agents Will Replace Traditional Apps as Wearable Tech Expands
, , ,

Qualcomm CEO Predicts AI Agents Will Replace Traditional Apps as Wearable Tech Expands

Qualcomm CEO Cristiano Amon has signaled a major shift in the consumer electronics landscape, revealing that the company is currently developing over 40 distinct AI-powered device designs. These new form factors, which range from smart jewelry and camera-equipped earbuds to wearable pins and advanced watches, are designed to function as constant companions that perceive the […]

Big Pharma’s Deep Pockets Challenge the Biotech IPO Revival as M&A Dominates
, , ,

Big Pharma’s Deep Pockets Challenge the Biotech IPO Revival as M&A Dominates

The market for biotechnology initial public offerings is showing signs of life after a prolonged period of stagnation, but emerging firms are finding themselves at a critical crossroads. Rather than braving the public markets, many high-quality biotech startups are opting for a “dual-track” strategy. This approach involves preparing for an IPO while simultaneously negotiating potential […]